Showing results (1421-1430 of 1,739) with videos related to

Sort By:
Pageof 174
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2026
DNA Methylation-based Risk Stratification and Classification of Pediatric Thyroid CarcinomaJenny Z Li, Julio Ricarte Filho, Amber R Isaza, et al.
American Journal of Ophthalmology|March 28, 2006
Influence of mutation type on clinical expression of Leber hereditary optic neuropathyLiesbeth Spruijt, Dinanda N Kolbach, Rene F de Coo, et al.
Studies in Health Technology and Informatics|September 8, 2000
Investigating 3D tumor distribution for optimized diagnosis of prostate cancerJ Zeng, J J Bauer, X Yao, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)Brandon M Barney, Svetomir N Markovic, Nadia N Laack, et al.
Thyroid : Official Journal of the American Thyroid Association|October 18, 2022
Impact of Definitive Surgery for Graves' Disease on Adolescent Disease-Specific Quality of Life and Psychosocial FunctioningStephen Halada, Julia A Baran, Amber Isaza, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 12, 2023
Comparison of Low-Level to High-Level Disinfection in Eliminating Microorganisms From Ultrasound Transducers Used on Skin: A Noninferiority Randomized Controlled TrialNathan Peters, Frances Williamson, Michelle J Bauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumorsS Goel, R J Bauer, K Desai, et al.
Pageof 174